Skip to main content
2025 Annual Scientific Meeting

Please log in to view your event registrations and bookings.

2025 Annual Scientific Meeting

Download Event to Calendar

 

After the success of our 2024 Annual Scientific Meeting in Manchester, we are excited to invite you to our 2025 meeting, which will be held at Churchill College, Cambridge.

Churchill College, part of the historic University of Cambridge, offers a distinguished and inspiring venue for our gathering. Cambridge itself is renowned for its beautiful architecture, rich academic heritage, and vibrant atmosphere, making it a perfect setting for our next meeting.

Building on the achievements of Manchester, the 2025 meeting will continue to deliver a diverse and engaging programme that spans the breadth of hypertension research and care. As always, there will be a strong focus on oral presentations, insightful lectures, and opportunities for networking with colleagues and distinguished guests.

The annual dinner will take place in Trinity Hall, a unique Cambridge venue, with further details to be announced soon. This promises to be a memorable evening and a highlight of the meeting.

We look forward to welcoming you to Cambridge and sharing another exceptional event with you.

For a PDF copy of the programme, please download HERE.

 

 

Organised by: BIHS Team of British and Irish Hypertension Society

2025 Annual Scientific Meeting

Travel and Parking

The nearest train stations are Cambridge, and Cambridge North. There is a bus stop at the end of our road which provides links to the train and bus stations.

The nearest airport is London Stansted. London Luton, London Heathrow, and London Gatwick airports are the next nearest airports.

There is limited parking for cars available on site, but visitors with access needs can contact the Porters Lodge to reserve a space. The College is a 25 minute walk from Madingley Road Park and Ride car park (CB3 0EU).

 

By Train

Trains run from Cambridge direct to Stansted airport. Further information about train services can be found on the National Rail website.

There is a bus stop 3 minutes walk from the Porters’ Lodge: head down Storeys Way towards the main road, and then turn left.

 

Agenda

Monday 29th September 2025

08:30

Registration and Exhibition


09:15

Session 1: Top ranked EMCR abstracts (Mark Glover award)

Opening Address
Abstracts
Visiting Prize Winner’ Abstract


10:45

Exhibition, Posters and Refreshments


11:15

Session 2: Genetics of Hypertension


Genetics of Hypertension – Where are we today? - Patricia Munroe
Applications and Utility of Blood Pressure Polygenic Risk Scores - Helen Warren
Genetic imputation of kidney transcriptome and proteome and their contribution to hypertension - Allen Xu


11:15

Parallel Session 1 - EMCR

Welcome: Why should you join the BIHS as an ECR? - Ryan McNally
Research Opportunities in Hypertension - Mark Caulfield
Dealing with career adversity: Not every career journey is an easy ride - Manish Sinha
Hear from the BIHS President: Hypertension as a specialty - Ian Wilkinson
Interactive Q&A Session - Carmel McEniery and Phil Chowienczyk


12:30

Symposium Session


12:55

Exhibition, Posters and Lunch


13:35

Symposium Session


14:00

Session 3: Open Abstracts

Abstract Presentations


14:00

Parallel Session 2: Resistant Hypertension


BIHS Guidelines - Luca Faconti
Submitted case studies


15:15

Poster Presentations

EMCR Poster Storm
Stanley Peart Prize winner


15:30

Moderated Poster Session, Refreshments and Exhibition


17:00

Annual General Meeting (BIHS members only)


Tuesday 30th September 2025

08:30

Registration and Exhibition


09:00

Session 4: Top ranked EMCR abstracts (Mark Glover award)


10:45

Session 5: Blood pressure management in Frailty


Management of blood pressure in patients with frailty - Jane Masoli
Management of hypertension in patients with symptomatic postural hypotension - Chris Clark
Deprescribing antihypertensive medication in older adults - James Sheppard


10:45

Parallel Session 3: Open Abstracts

Open Abstracts
Visiting Prize Winner’ Abstract


11:45

Sir George Pickering Lecture


12:45

Symposium Session


13:10

Exhibition, Posters and Lunch


13:50

Symposium Session


14:15

Session 6: Ethnicity and hypertension: Results from the AIMHY project


Introduction to AIMHY - Phil Chowienczyk
AIMHY Mono Trial - Luca Faconti
AIMHY Dual Trial - Ian Wilkinson


14:15

Parallel 4: Open Abstracts


15:15

Exhibition, Posters and Refreshments


15:45

Session 7: Latest research in hypertension


A year in Hypertension - Anthony Heagerty
New drugs for hypertension coming to market - Manish Saxena
Biomarkers in Urine, anTihypeRtensive trEAtment and blood pressure Control in Hypertensive patients – The OUTREACH Study - Pankaj Gupta


16:45

Prize Giving and Closing Remarks

 

Download the programme HERE

*This programme is subject to change

 

 


Agenda subject to change

Speakers

Vice Principal for Health for Queen Mary’s Faculty of Medicine and Dentistry

At Queen Mary University of London, Mark Caulfield has made contributions to the discovery of genes related to blood pressure, cardiovascular health, cancer and rare diseases. His research has changed national and international guidance for high blood pressure. Mark was appointed Chief Scientist for Genomics England in 2013, charged with delivery of the 100,000 Genomes Project on whole genome sequencing in rare disease, cancer and infection. He was instrumental in delivering the 100,000 Genomes Project which has delivered life-changing results for many patients. He worked with NHS England to co-create the National Genomic Test Directory, which offers equitable access for 56 million people to appropriate genomic tests.  Mark was awarded a knighthood in 2019 for his leadership of the 100,000 Genomes Project.

He is a member of the Barts Health NHS Trust Board, the Barking, Havering and Redbridge University Hospitals NHS Trust, the MedCity Board and is the President Elect of the British Pharmacological Society

Professor of Cardiovascular Clinical Pharmacology at the School of Cardiovascular Medicine & Sciences, King’s College London and Vice President of the BIHS

Phil Chowienczyk worked in biomedical engineering before studying medicine at Guy’s Hospital Medical School. His research relates to the in vivo assessment of cardiovascular structure and function in humans with the aim of elucidating mechanisms leading to arterial disease and interventions to prevent/treat arterial disease. Phil currently leads a programme on stratified mechanisms in hypertension. He retains an interest in biomedical engineering in relation to non-invasive assessment of cardiovascular function.

Associate Professor of Primary Care Cardiovascular Medicine and Chair of the BIHS BP Measurement Committee

Chris Clark studied Medicine and Physiology at University of Bristol Medical School, graduating in 1986. He joined the Mid Devon Medical Practice in 1994 as a partner, then Senior Partner, and continued working there until December 2020. He joined the Medical School as an Clinical Academic Fellow in 2004, completed his MSc in 2006 and his PhD in 2013 and was appointed NIHR Clinical Lecturer in 2014 then Clinical Senior Lecturer in 201

Consultant Nephrologist at Heart of England NHS Foundation Trust, is an Honorary Senior Lecturer at the University of Birmingham, and is the Chair of the BIHS Research Committee

Indranil Dasgupta's research interests include treatment resistant hypertension. He is Clinical Research Lead Division 2 for Renal, Stroke, CVD, Diabetes and Metabolic Diseases for the West Midlands in NIHR Clinical Research Network, Honorary Secretary of the Renal Association UK, and a member of the research working party for the British and Irish Hypertension Society. He also serves as an expert adviser for the National Institute for Health and Care Excellence.

Clinical Lecturer in the Department of Clinical Pharmacology at King's College London and Honorary Consultant at Guy's and St Thomas' NHS Foundation Trust, BIHS Treasurer

Luca Faconti completed his medical training in Pisa (ESH Excellence Centre) and started his involvement in the BIHS as the Young Investigator Representative (2019 to 2022). His research focuses on hypertension and hypertension mediated target organ damage including arterial stiffness and cardiac remodelling. He has extensive expertise in non-invasive assessment of cardiovascular structure and function using multi-modality imaging.

Professor of Cardiovascular Medicine & Therapeutics at the University of Dundee Medical School

Jacob George is a Consultant Physician qualified in Clinical Pharmacology and General Internal Medicine and is an accredited European Hypertension Specialist.  His clinical interest is in managing patients with high Cardiovascular risk and he is Clinical Lead for the Cardiovascular Risk Service in NHS Tayside. His research interests are focused on managing cardiovascular risk factors such as left ventricular hypertrophy, salt and smoking/vaping. His research publications have been covered by more than 50 news organizations worldwide and he has conducted more than 80 media interviews including live television broadcasts to national and international media on the results of his research.

 

Consultant Chemical Pathologist and Metabolic Physician at the University Hospitals of Leicester NHS Trust and an Honorary Associate Professor in the Department of Cardiovascular Medicine, University of Leicester and Member if the BIHS Executive Committee

Pankaj Gupta runs the Hypertension Clinic (European Centre of Excellence) at Leicester, and is the lead for the Lipid Clinic. His main research is in the field of chemical detection of non-adherence and was one of the first to develop the method to detect multiple antihypertensives in a single urine sample.  This has led to the setup of the National Centre for Adherence Testing in Leicester of which he is the Co-director. 

Head of the School of Medical Sciences, The University of Manchester

Tony Heagerty was a Founding Member of the Academy of Medical Sciences and formerly a Member of the Academic Medicine Committee. He serves on the Nominations Committee of the Royal College of Physicians. He is a former President of the European Society of Hypertension and the International Society of Hypertension. He served as a Member of the British Heart Foundation until 2010. In 2009, he was elected Vice-President of the British Hypertension Society and is currently the serving President. Tony Heagerty was a Founding Member of the Academy of Medical Sciences and formerly a Member of the Academic Medicine Committee. He serves on the Nominations Committee of the Royal College of Physicians.  His clinical interests are in high blood pressure and cardiovascular diseases. Most recently, he led the successful application to designate Manchester as a European Society of Hypertension Centre of Excellence and introduced renal denervation in collaboration with the Department of Radiology and the Manchester Heart Centre at Central Manchester Healthcare Trust. 

He is an international authority on high blood pressure and is regularly invited to give lectures at international meetings.

 

Associate Professor of Ageing Research and Honorary Consultant Geriatrician at the Royal Devon University Healthcare NHS Trust

Jane Masoli leads the AGE (Ageing and long-term conditions, Genomics and Epidemiology) Group. AGE Research Group > AGE @ Exeter. Her primary research interest is in data approaches to cardiovascular frailty and multiple long-term conditions and she is funded by an NIHR Advanced Fellowship focussed on cardiovascular frailty and is a work package lead for the GEMINI Multiple Long-Term Conditions collaborative.

Jane supervises PhD students in cardiovascular frailty and multiple long-term conditions and am open to email enquires from students with their own funding interested in pursing a PhD in these areas. The AGE group also provides clinical academic training and mentorship for the NIHR Integrated Academic Training pathway, and she is primary supervisor for two academic clinical fellows.

 

Postdoctoral Research Associate in the Department of Vascular Risk and Surgery, School of Cardiovascular Medicine and Sciences, Faculty of Life Sciences and Medicine, and member of the BIHS Executive Committee

Ryan McNally's postdoctoral research project was a joint clinical study between King’s College London and the University of Cambridge investigating salt-sensitivity in the pathogenesis of hypertension. He is now conducting research into personalised medicine for hypertension at the King's Health Partners Centre for Translational Medicine and is working as a pharmacist at St. Thomas' Hospital. Ryan is also member of the European Society of Hypertension Young Investigator Committee.

Senior Research Associate in the Division of Experimental Medicine and Immunotherapeutics Fellow and College Lecturer in Physiology

Carmel McEniery is a Principal Research Associate in the Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, and a College Lecturer in Physiology at Churchill College, Cambridge. Her key research interests are the mechanisms driving the development of hypertension in young adults, and how blood pressure and its underlying haemodynamic mechanisms differ between the sexes and change across the adult age-span. Dr McEniery is the current President of the ARTERY Society and has previously served on the BIHS Executive Committee both as an ordinary member and Secretary. She is currently a member of the BIHS Education Committee.

Professor of Molecular Medicine, Centre Lead for Clinical Pharmacology and Precision Medicine, Director of the Genome Centre at FMD and an Adjunct Professor at the Department of Physiology and Pharmacology, The University of Toledo, USA

Patricia Munroe's lab investigates the molecular basis of cardiac arrythmia’s, hypertension and heart failure. Their research includes genomic studies of cardiovascular risk factors as a route for elucidating disease mechanisms, the development of ‘omic biomarkers and clinical models for improved risk prediction, pharmacogenetics and personalised medicine. She co-leads several international complex genetic disease consortia. Using meta-analysis of genome-wide association studies (GWAS) and large-scale candidate gene studies she has discovered over 1000 genetic loci associated with hypertension.  She has also identified hundreds of genetic loci for the electrocardiogram and cardiac magnetic resonance measures of heart structure and function.

Physiotherapist, specialising in Frailty, working in NHS Community Services and member of the BIHS Executive Committee

Prior to this role Sam Olden spent several years working in cardiac rehabilitation and preventative cardiac health management in London, which sparked his interest in Hypertension. He has carried through to his Frailty work, with particular interest in non-pharmacological interventions for blood pressure management in the older adult.

Cardiovascular Physician and Hypertension Specialist at Barts Health NHS Trust and Queen Mary University London, Member of the BIHS Executive Committee

Manish Saxena's research interest is in developing novel therapies to improve patient outcomes and prevention of cardiovascular/metabolic diseases. He is UK lead on academic and commercial studies with pharmaco-therapy and devices in dyslipidaemia, obesity, hypertension, heart failure, diabetes, inflammation and anti-coagulation. Manish works closely with Health Research Authority as an expert member and  National Research Ethics Committee Chair. He is Deputy Director for research at Barts Health NHS Trust and QMUL. He has been recognised as leading Principal investigator by NIHR

Associate Professor in Applied Health Research at the University of Oxford, and Secretary of the BIHS Executive Committee

James Sheppard's research focusses on better understanding the benefits and harms of commonly prescribed treatments, with a particular emphasis on medications used for cardiovascular disease prevention. His work involves systematic reviews, statistical modelling, epidemiology and primary care based clinical trials

Paediatric Nephrologist

With nearly 20 years of clinical experience, Manish Sinha has worked at two of the largest paediatric nephrology centres in the UK, including in London and Manchester.

He received his PhD from King’s College London and is an expert in the management of cardiovascular diseases in children with kidney diseases and those with hypertension.

Senior Lecturer at the William Harvey Research Institute, Queen Mary University of London, and member of the BIHS Executive Committee

Helen Warren works in the field of cardiovascular genetics. Her research focuses on the genetic discovery for blood pressure, risk prediction for hypertension, and pharmacogenetics for the response to both antihypertensive drugs and statins. She is the lead genetic analyst for ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) and BRIGHT (British Genetics of Hypertension study). Helen is a senior leader of the International Consortium of Blood Pressure, the Genomic Investigation of Statin Therapy Consortium, and International Consortium for Antihypertensive Pharmacogenetics Studies. Helen has been a BIHS member since 2014, a Trustee & Executive Committee member since 2024, and a Collaborative Research Committee member since 2017.

Clinical Pharmacologist, Professor of Therapeutics at the University of Cambridge and Honorary Consultant Physician at Addenbrooke’s Hospital.

Ian Wilkinson leads the regional secondary/tertiary care hypertension service, directs the Cambridge Clinical Trials Centre, and is a Non-Executive Director of Royal Papworth Hospital. Ian's research centres on the pathophysiology of hypertension and its treatment. He has a broad research portfolio including national trials and cohort studies with a wide range of funders including the NIHR, MRC and BHF.

Research Fellow in the Division of Cardiovascular Sciences at the University of Manchester

Allen Xu is a BHF Manchester Centre for Research Excellence Research Fellow. His research focuses on integrating multi-omics, statistical modelling, and genetics to uncover gene regulatory mechanisms underlying cardiovascular and kidney diseases. He is currently a professional member of the International Society of Hypertension.

Prices

Please find a list of tickets for this event below.

Advance booking is available from 6 May 2025 until 31 July 2025.

Late booking is available from 1 August 2025 until 19 September 2025.

Ticket Advance booking Late booking
Industry £500.00 £600.00
Member - 2 day ticket - Consultant/GP £350.00 £400.00
Member - 2 day ticket - SpR, Scientist, Pharmacist, AHP £250.00 £300.00
Member - 2 day ticket - Student £150.00 £175.00
Non Member - 2 day ticket - GP/Consultant £450.00 £550.00
Non Member - 2 day ticket - SpR, Scientist, Pharmacist, AHP £350.00 £420.00
Non-member - 2 day ticket - Student £250.00 £320.00

Delegate Terms and Conditions

Please ensure you read the terms and conditions. If you purchase a ticket, you agree the the following terms and conditions.

Member Tickets

Members tickets are available to those delegates holding a British and Irish Hypertension Society (BIHS) Membership up to and during the Annual Scientific Meeting 2025. Any delegates purchasing tickets with expired or non-renewed memberships, will be asked to renew their membership prior to the meeting, if the membership is not renewed then the ticket will be cancelled so that a non-members ticket can be purchased.

If you need to check your membership, please login HERE.

Memberships are for HCPs only.

Industry Personnel Tickets

Tickets are available for industry medical professionals. Please ensure you purchase the correct ticket.

Student Tickets

Students may attend educational sessions but are not permitted to access pharmaceutical exhibition stands or receive promotional materials, in accordance with the ABPI Code of Practice.

To qualify for a student ticket, you should be an undergraduate. You will be asked to provide evidence of your student status.

Payments and Payment Methods

Where an event fee applies, event bookings will generate an invoice. This will be issued to the delegate via our bookings platform on the BIHS website.

Payment methods accepted are credit/debit card and purchase orders from institutions only.

Tickets can be purchased directly from the BIHS website for payment by credit/debit card.

For payments by purchase order, please send an email to info@bihs.org.uk. You will be sent a form to complete where you will need to upload a copy of your purchase order. Tickets will not be reserved until a purchase order has been uploaded, the form completed and an invoice sent from BIHS.

Invoices must be settled within 30 days of the date of issue, but not later than 14 days prior to the first day of the event.

Purchase Orders must contain the following information:

- Names and emails of all delegates

- Name and address of the organisation

- Purchase order number

- Ticket type and fees

- BIHS Membership number if a member

Without the correct information, the purchase order cannot be processed. Purchase orders must be submitted by Friday 5 September at 5pm BST. Registration by purchase order will close on this date.

Please note that there is no VAT charged on tickets.

CPD

To ensure you receive your full CPD points, please ensure you ‘check-in’ at the event on both days. The person named on the registration will be the ONLY person to receive an attendance and CPD certificate after the event.

Cancellation or postponement of event

In the unlikely circumstance that BIHS Society has to cancel the event, we will refund any pre-paid registration fees.

BIHS reserves the right to change the event venue within 10 miles of the advertised venue.

BIHS shall not be liable for reimbursing the cost of travel or accommodation arrangements booked by those attending a BIHS event.

In the event of a postponement, all tickets will automatically be valid for the new date, or transferable to someone else in the same ticket pricing bracket. Refunds will be available if you are unable to make the new event date.

Cancellation of attendance at an event

Please let us know if you cannot attend the event as soon as possible by emailing: info@bihs.org.uk  

Where a fee has been charged, you will be reimbursed as follows:

  • For cancellations up until midnight, eight weeks prior to the first day of the event a 100% refund will be given. An administration fee may be charged
  • For cancellations up until midnight, six weeks prior to the first day of the event a 50% refund will be given.
  • For registrations cancelled after midnight, four weeks prior to the first day of the event, or for failure to attend the conference, no refund will be given.
  • Changes will incur an administration fee as stipulated below

To cancel or amend a booking, please email info@bihs.org.uk  

Meeting Access

Please note the following: 

  • Delegates will only be able to access the meeting with their own ticket

Name Changes

Tickets are transferable: it will be possible to amend the name on your in-person ticket to a colleague within the same ticket pricing bracket [member or non-member; SpR/AHP; consultant /GP; industry]:

  • For name changes up until midnight, four weeks before the first day of the event, there will be no charge.
  • For name changes up until midnight, 5 working days before the first day of the event, there will be a £20 administrative fee per ticket.
  • Within 5 working days of the first day of the event, name changes will not be possible.

To arrange for a name change, contact info@bihs.org.uk

Force Majeure

For the purpose of these terms and conditions, "force majeure" means any cause beyond our reasonable control including, but not limited to, war, acts of terrorism, governmental requirements, acts of local or central government or other competent authorities, acts of God and industrial disputes.

We will not be liable to you for failure to perform any obligation under these terms and conditions or in relation to your booking to the extent that the failure is caused by force majeure.

Recording disclaimer

During this event we may do one or all of the following:

  • Take general photographs at the event
  • Record audio output from the event
  • Video record the event proceedings

Any subsequent photographs or recordings may be used in future BIHS publicity materials only.

All video and audio recordings and photographs will remain the property of BIHS. By registering for this event, you are agreeing to the photographing and/or recording and/or filming of the proceedings, as described above, being made for future dissemination by BIHS.

If you DO NOT wish to be photographed or video recorded, please let the organisers know on arrival at the physical event, or email info@bihs.org.uk

Conditions of attendance

You must comply with instructions and directions given by staff, BIHS, stewards and agents of the venue (where relevant) and any applicable policies and procedures of which you are notified.

We reserve the right to refuse access to, or remove any delegate from the BIHS event who, in our reasonable opinion has, or is likely to affect the experience of the other delegates, in our reasonable opinion is acting under the influence of alcohol or drugs, or who uses threatening, abusive or insulting words or behaviour or who behaves in a manner which may cause a breach of the peace.

BIHS is dedicated to creating and maintaining a positive event experience where everyone is treated with dignity, courtesy and respect.

Any discriminatory language and imagery are not appropriate at the BIHS event, including in presentation material. Violation of these rules could result in exclusion from the event without a refund.

Privacy

What information we collect:

When you sign up on our website to attend an event or to receive news from us, we will collect and process your data to allow us to carry out your request.

This information will typically include your name, email address, and company/institution.

For paid-for events, financial data including your billing address will also be collected and processed by a third-party processor. Our online security controls maintain confidentiality at all times, specifically for secure card payments. We are certified to the payment card data security standards (PCI-DSS) and never store card details.

For events, we may also ask for any special dietary and disability requirements which we will pass onto the venue/accommodation provider in order to help us make your attendance at the event as comfortable as possible. Providing this information will always be optional.

We may also retain copies of documents you provide to us as proof of your identity (including passport details) for example when you are claiming a financial bursary award.  Along with your bank details, we may also keep copies of travel and accommodation receipts if claiming expenses.

Why we collect and process this information and how we will use it:

When you sign up to attend a conference/event, we will use your information to process this request. This may include:

  • Contacting you before the event with important information, and in some cases immediately afterwards to share any presentations or reports associated with the conference/event.
  • Making a name badge for you, which will contain your full name, organisation and country
  • Producing a delegate list with your full name, company and country to be handed out to all attendees of the event including exhibitors/sponsors either as a printed document or electronically.  You will always have the option to ask for your name to be withdrawn from this list.

When you sign up to receive news from us, either via the mailing list form or when you sign up to attend a conference/event and give us permission to contact you in future, we will use your data to send you regular emails about upcoming events or research which we think you might be interested in.

We will not share your personal data with any other third-party, unless we have expressly asked permission from you to do so (for example, if we are running a joint conference/event with another organisation, we may ask for your permission to share your details with them).

Lawful basis for processing this information:

The lawful basis for processing this information is Legitimate Interests (Article 6(1)(f)).

For anyone who has signed up to attend a conference/event, we have a legitimate interest in processing their data in order to facilitate the running of the event. You have a legitimate interest in us processing the data in this way, as it allows you to attend the event.

We have a legitimate interest in informing members of the public who have expressed an interest in our work (either by directly signing up on our website, or by attending an event and opting in to hearing more about similar events or research) about these topics.

How long we keep your information:

We will only hold your personal information on our systems for as long as is necessary to carry out the above uses. For example:

  • If you sign up to an event, we will store your data for up to five years after the event. After this period, we will anonymise all data on attendees and keep only attendance numbers and a broad breakdown by sector.
  • If you sign up to our mailing list, we will store your data either until you unsubscribe (there will always be an option to opt-out on every email we send).

If you have any questions on the terms and conditions, please contact us info@bihs.org.uk

Abstract Details

 

Abstract submisson is now open for the BIHS Annual Scientific Meeting 2025. As well as the opportunity to qualify for an oral presentation or a poster, the top ranked abstracts will also be in the running to win one of the following:

  • Mark Glover Award - £1000 towards travel to the Hypertension Australia ASM to give a presentation. Open only to Early Career Researchers who are BIHS members.
  • £500 travel prize to present at the Italian Society of Hypertension meeting - Open only to Early Career Researchers who are BIHS members.
  • Robert Grayson Award of £150 for research on the aorta or blood vessels
  • Best poster prizes of £100 and publication in the Journal of Human Hypertension (JHH) (subject to acceptance by the JHH)

Please ensure you have read the full terms and conditions before submitting your application. Any applications not following the full terms and conditions will be automatically disregarded.

Terms and Conditions

If you would like your abstract to be considered for some of the awards, you will need to be a BIHS member. Please click the button below to join us.

Become a BIHS Member

We look forward to receiving your submission.

Submit your Abstract